Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CoreRx, Aimmune Unveil Joint Expansion | Contract Pharma
Breaking News, Collaborations & Alliances

CoreRx, Aimmune Unveil Joint Expansion

Together will advance treatment of peanut and other food allergies

CoreRx, a contract development and manufacturing organization (CDMO), and Aimmune Therapeutics, a clinical-stage biopharmaceutical company advancing a therapeutic approach for the treatment of peanut and other food allergies, together, have increased manufacturing operations at CoreRx’s ICOT Center campus in Clearwater, FL.

This new expansion consists of approximately 20,000 square feet of manufacturing and warehouse space at CoreRx’s 5733 Myerlake Circle (ML-3) location. This growth will necessitate additional staffing at CoreRx including positions within pharmaceutical development, manufacturing, engineering, quality assurance and packaging.

“The Tampa Bay area is a great place to expand the base of scientific capabilities,” said said Todd Daviau, president and chief executive officer, CoreRx. “These expansions in the private-sector result in high-paying, skilled roles that contribute immensely to society by providing products and services that impact the quality of lives of Americans. These expansions continue to showcase the Tampa regions expertise in high technology manufacturing on a national and global level. And, we will continue to expand our capabilities to meet the growing demands of our clients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters